Clinical usefulness of multiple arterial-phase images in gadoxetate disodium-enhanced magnetic resonance imaging: a systematic review and meta-analysis
- PMID: 35192009
- DOI: 10.1007/s00330-022-08620-x
Clinical usefulness of multiple arterial-phase images in gadoxetate disodium-enhanced magnetic resonance imaging: a systematic review and meta-analysis
Abstract
Objectives: The multiple arterial-phase (AP) technique was introduced for liver MRI, but it is not really known if multiple AP MRI (MA-MRI) improves image quality and lesion detection rate on gadoxetate disodium-enhanced MRI in comparison with single AP MRI (SA-MRI). We aimed to determine the clinical usefulness of MA-MRI in comparison with SA-MRI.
Methods: Original articles reporting the percentage of adequate AP imaging and the lesion detection rate on gadoxetate disodium-enhanced MA-MRI were identified in PubMed, EMBASE, and Cochrane Library databases. The pooled percentage of adequate AP imaging and lesion detection rate were calculated using random-effects meta-analysis of single proportions. Subgroup analysis was performed to explain causes of study heterogeneity, and publication bias was evaluated using Egger's test.
Results: Of 772 articles screened, 22 studies in 12 articles were included: 18 studies (ten MA-MRI and eight SA-MRI) suitably defined the percentage of adequate AP imaging and four (three MA-MRI and one SA-MRI) defined the lesion detection rate. MA-MRI had 16.1% higher pooled percentage of adequate AP imaging than SA-MRI (94.8% vs. 78.7%, p < 0.01). MA-MRI additionally detected 33.2% of lesions than SA-MRI (83.2% vs. 50.0%, p = 0.06). Substantial study heterogeneity was found in MA-MRI, and the definition of adequate AP imaging, lesion characteristics, and reference standards were significant factors affecting study heterogeneity (p ≤ 0.02). Significant publication bias was found in MA-MRI (p < 0.01) but not in SA-MRI studies (p = 0.87).
Conclusions: Gadoxetate disodium-enhanced MA-MRI may be more clinically useful than SA-MRI, but further study is necessary to validate this finding because of study heterogeneity and publication bias.
Key points: • Multiple arterial-phase MRI (MA-MRI) had a 16.1% higher pooled percentage of adequate AP imaging than single arterial-phase MRI (SA-MRI) (94.8% vs. 78.7%, p < 0.01). • MA-MRI additionally detected an extra 33.2% of lesions compared with SA-MRI (83.2% vs. 50.0%, p = 0.06). • Substantial study heterogeneity and significant publication bias were found across MA-MRI studies.
Keywords: Detection; Liver; Magnetic resonance imaging; Meta-analysis.
© 2022. The Author(s), under exclusive licence to European Society of Radiology.
Similar articles
-
Gadoxetate disodium-related event during image acquisition: a prospective multi-institutional study for better MR practice.Eur Radiol. 2020 Jan;30(1):281-290. doi: 10.1007/s00330-019-06358-7. Epub 2019 Jul 23. Eur Radiol. 2020. PMID: 31338655
-
Compressed Sensing and Parallel Imaging for Double Hepatic Arterial Phase Acquisition in Gadoxetate-Enhanced Dynamic Liver Magnetic Resonance Imaging.Invest Radiol. 2019 Jun;54(6):374-382. doi: 10.1097/RLI.0000000000000548. Invest Radiol. 2019. PMID: 30724814
-
Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma.J Hepatol. 2019 Sep;71(3):534-542. doi: 10.1016/j.jhep.2019.05.005. Epub 2019 May 18. J Hepatol. 2019. PMID: 31108157
-
Detection of liver metastases on gadobenate dimeglumine-enhanced MRI: systematic review, meta-analysis, and similarities with gadoxetate-enhanced MRI.Eur Radiol. 2019 Oct;29(10):5205-5216. doi: 10.1007/s00330-019-06110-1. Epub 2019 Mar 26. Eur Radiol. 2019. PMID: 30915560
-
Diagnostic performance of CT, gadoxetate disodium-enhanced MRI, and PET/CT for the diagnosis of colorectal liver metastasis: Systematic review and meta-analysis.J Magn Reson Imaging. 2018 May;47(5):1237-1250. doi: 10.1002/jmri.25852. Epub 2017 Sep 13. J Magn Reson Imaging. 2018. PMID: 28901685
Cited by
-
Are dilution, slow injection and care bolus technique the causal solution to mitigating arterial-phase artifacts on gadoxetic acid-enhanced MRI? A large-cohort study.Eur Radiol. 2024 Aug;34(8):5215-5227. doi: 10.1007/s00330-024-10590-1. Epub 2024 Jan 20. Eur Radiol. 2024. PMID: 38243134 Free PMC article.
-
Deep learning-based image reconstruction for the multi-arterial phase images: improvement of the image quality to assess the small hypervascular hepatic tumor on gadoxetic acid-enhanced liver MRI.Abdom Radiol (NY). 2024 Jun;49(6):1861-1869. doi: 10.1007/s00261-024-04236-5. Epub 2024 Mar 21. Abdom Radiol (NY). 2024. PMID: 38512517
-
The timing phase affected the inconsistency of APHE subtypes of liver observations in patients at risk for HCC on the multi-hepatic arterial phase imaging.Abdom Radiol (NY). 2024 Apr;49(4):1092-1102. doi: 10.1007/s00261-023-04096-5. Epub 2024 Jan 10. Abdom Radiol (NY). 2024. PMID: 38195799
-
Liver metastases: The role of magnetic resonance imaging.World J Gastroenterol. 2023 Sep 28;29(36):5180-5197. doi: 10.3748/wjg.v29.i36.5180. World J Gastroenterol. 2023. PMID: 37901445 Free PMC article. Review.
-
CT/MRI technical pitfalls for diagnosis and treatment response assessment using LI-RADS and how to optimize.Abdom Radiol (NY). 2025 May;50(5):2022-2037. doi: 10.1007/s00261-024-04632-x. Epub 2024 Oct 22. Abdom Radiol (NY). 2025. PMID: 39433603 Review.
References
-
- Fowler KJ, Brown JJ, Narra VR (2011) Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis. Hepatology 54:2227–2237 - DOI
-
- Huh J, Kim SY, Yeh BM et al (2015) Troubleshooting arterial-phase MR images of gadoxetate disodium-enhanced liver. Korean J Radiol 16:1207–1215 - DOI
-
- Chernyak V, Fowler KJ, Kamaya A et al (2018) Liver Imaging Reporting and Data System (LI-RADS) Version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology 289:816–830 - DOI
-
- Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52–60 - DOI
-
- European Association for the Study of the Liver (2018) EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 69:182–236
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical